Order Article Reprints

Papa A, Scaldaferri F, Covino M, Tursi A, Furfaro F, Mocci G, Lopetuso LR, Maconi G, Bibbò S, Fiorani M, et al. Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. Biomedicines. 2022; 10(4):843. https://doi.org/10.3390/biomedicines10040843

Papa, Alfredo, Franco Scaldaferri, Marcello Covino, Antonio Tursi, Federica Furfaro, Giammarco Mocci, Loris Riccardo Lopetuso, Giovanni Maconi, Stefano Bibbò, Marcello Fiorani, and et al. 2022. "Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study" Biomedicines 10, no. 4: 843. https://doi.org/10.3390/biomedicines10040843

Papa, A., Scaldaferri, F., Covino, M., Tursi, A., Furfaro, F., Mocci, G., Lopetuso, L. R., Maconi, G., Bibbò, S., Fiorani, M., Laterza, L., Mignini, I., Napolitano, D., Parisio, L., Pizzoferrato, M., Privitera, G., Pugliese, D., Schepis, T., Schiavoni, E., ... Gasbarrini, A. (2022). Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. Biomedicines, 10(4), 843. https://doi.org/10.3390/biomedicines10040843